大博医疗持股5%以上股东拟减持不超828.04万股

Group 1 - The core point of the news is that Dabo Medical Technology Co., Ltd. has announced a share reduction plan by its major shareholder, Dabo International Investment Co., Ltd. [1] Group 2 - As of the announcement date, Dabo International holds 82,926,901 shares, representing 20.03% of the total share capital of 414,019,506 shares, and 20.39% when excluding repurchased shares [2] - Dabo International plans to reduce its holdings by up to 8,280,390 shares, which is 2.00% of the total share capital, within a three-month period starting from September 18, 2025, to December 17, 2025 [2] - The shares to be reduced are from the pre-IPO holdings, and the reduction price will be determined based on the market price at the time of the sale [2] Group 3 - Dabo International has previously made commitments regarding share lock-up and reduction, including not transferring shares within 36 months post-listing and ensuring the reduction price does not fall below the issue price within two years after the lock-up period [3] - As of the announcement date, Dabo International has adhered to these commitments, and the current reduction plan does not violate any of these promises [3] Group 4 - The implementation of the reduction plan carries uncertainties, as Dabo International will decide based on market conditions and share price whether to proceed with the full or partial reduction [4] - However, this reduction is considered a normal action and is not expected to significantly impact the company's governance structure, ownership, or ongoing operations [4] - The reduction plan complies with relevant laws and regulations [4]